Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Net Cash Flow: 2016-2024

Historic Net Cash Flow for Krystal Biotech (KRYS) over the last 9 years, with Dec 2024 value amounting to -$13.0 million.

  • Krystal Biotech's Net Cash Flow rose 40.11% to $39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 2411.52%. This contributed to the annual value of -$13.0 million for FY2024, which is 106.62% down from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Net Cash Flow is -$13.0 million, which was down 106.62% from $196.6 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Net Cash Flow ranged from a high of $196.6 million in FY2023 and a low of -$179.3 million during FY2022.
  • For the 3-year period, Krystal Biotech's Net Cash Flow averaged around $1.4 million, with its median value being -$13.0 million (2024).
  • Per our database at Business Quant, Krystal Biotech's Net Cash Flow tumbled by 345.70% in 2022 and then spiked by 209.64% in 2023.
  • Over the past 5 years, Krystal Biotech's Net Cash Flow (Yearly) stood at $80.8 million in 2020, then dropped by 9.63% to $73.0 million in 2021, then slumped by 345.70% to -$179.3 million in 2022, then spiked by 209.64% to $196.6 million in 2023, then plummeted by 106.62% to -$13.0 million in 2024.